Literature DB >> 8169502

Vocal process granulomata.

D J McFerran1, V Abdullah, A P Gallimore, M B Pringle, C B Croft.   

Abstract

The case records and histology of 34 patients with vocal process granulomata were reviewed. The five patients presenting most recently with idiopathic vocal process granulomata were investigated by axial computerized tomography (CT). Increased density of the arytenoid cartilage on the side of the lesion was found in all five cases. It is suggested that this indicates cartilage ossification, secondary to perichondritis. This perichondritis, playing either a primary or a secondary role in granuloma development, may explain the annoying tendency of vocal fold granulomata to recur after excision.

Entities:  

Mesh:

Year:  1994        PMID: 8169502     DOI: 10.1017/s0022215100126337

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  5 in total

1.  Ideal Particle Sizes for Inhaled Steroids Targeting Vocal Granulomas: Preliminary Study Using Computational Fluid Dynamics.

Authors:  Elizabeth L Perkins; Saikat Basu; Guilherme J M Garcia; Robert A Buckmire; Rupali N Shah; Julia S Kimbell
Journal:  Otolaryngol Head Neck Surg       Date:  2017-11-21       Impact factor: 3.497

2.  Functional and clinical anatomy of the posterior insertion of the human vocal ligament.

Authors:  F Paulsen; B Tillmann
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

Review 3.  Diagnostically challenging lesions in head and neck pathology.

Authors:  L D Thompson
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

4.  Potassium titanyl phosphate laser treatment of intubation vocal granuloma.

Authors:  Deng-Shan Lin; Shu-Chu Cheng; Wan-Fu Su
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-03-04       Impact factor: 2.503

5.  Worst-case scenario intubation of laryngeal granuloma: a case report.

Authors:  Junko Nakahira; Toshiyuki Sawai; Sayuri Matsunami; Toshiaki Minami
Journal:  BMC Res Notes       Date:  2014-02-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.